Since the foundation of Eufoton, the 808 nm wavelength of the various versions of the LASEmaR® 800 has historically been the first to be developed in the vascular field. For the company it is therefore a gold standard for dermatology and phlebology for various vascular solutions, documented by the numerous consolidated operating protocols in almost 20 years of application experience.
Its main feature is high affinity for bone chromophores and deoxyhemoglobin and a very low interference from tissue water.
The LASEmaR® 800 is therefore indicated in vascular dermatology for the peritoneal treatment of all major telangiectases, including those on the face (i.e. nostrils) where all visible wavelengths (blue, green, yellow lasers or pulsed light) have difficulty and penetration limits. As documented by years of experience, telangiectases on the lower limbs respond well to percutaneous treatment with LASEmaR® 800, especially in select cases that are also associated with previous sclerotherapy. For dermatologists who also deal with phlebology, it is important to present FLEBOLASER, a combined exo/endo dermal method with LASEmaR® 800 for the combined treatment of telangiectases and reticular veins of the legs.
Percutaneous treatment with LASEmaR® 800 is ideal for treating small isolated and superficial ectases (approximately 1 mm in diameter); for cases of telangiectases subject to mixed or deep reflux (more than 1 mm in diameter), where sclerotherapy seemed to be the first option, transdermal treatment can work in synergy with an endo-perivenous treatment by means of optical microfibers, in order to achieve better and faster results without the typical chemical limit of the sclerosing drug.
Transdermal or endo-perivenous laser treatment of telangiectases combined with a suitable skin cooling system is always preferred over chemical sclerosis in patients with previous systemic or local allergic manifestations, pigmentations, matting and those who have a phobia for needles.Likewise, the endo-perivenous method with LASEmaR® 800 proposed for reticular, perforator and trunk varicose veins is ideal in cases where surgical phlebectomy would cause undesired scarring due to keloid proneness or where chemical sclerotherapy would produce aesthetically unpleasant depigmentations.
LASEmaR® 940 utilizes the 940 nm wavelength which is a valid and effective alternative to the 808 nm wavelength for transdermal treatment of telangiectasias because it has a higher haemoglobin absorption; due to its activity with water, it cannot however be used for endo-perivenous treatment
Spider vein - Courtesy of L. Scrimali, MD